Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29702-29712

  Foster, James D ^a   Yang, Jae Won ^b   Moritz, Amy E ^a   ChallaSivaKanaka, Sathyavathi ^a   Smith, Margaret A ^a   Holy, Marion ^b   Wilebski, Kyle ^a   Sitte, Harald H ^b   Vaughan, Roxanne A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEMS; DOPAMINE TRANSPORTERS; DOPAMINE TRANSPORTS; HETEROLOGOUS EXPRESSION; PHORBOL ESTERS; PHOSPHORYLATION SITES; PROTEIN KINASE C; PROTEIN PHOSPHATASE; SIGNALING PATHWAYS; TRANSPORT ACTIVITY; TRANSPORT KINETIC;

AMINES; AMINO ACIDS; MASS SPECTROMETRY; NEUROPHYSIOLOGY; STOICHIOMETRY; TISSUE;

PHOSPHORYLATION;

AMPHETAMINE; DOPAMINE TRANSPORTER; THREONINE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT;

AMINO ACID SUBSTITUTION; AMPHETAMINE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TUMOR; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MUTATION, MISSENSE; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; SWINE; THREONINE;

RATTUS; RODENTIA;

EID: 84865454292     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.367706     Document Type: Article

References (77)

1. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612
2. Torres, G. E. (2006) The dopamine transporter proteome. J. Neurochem. 97, Suppl. 1, 3-10
3. Lu, L., Koya, E., Zhai, H., Hope, B. T., and Shaham, Y. (2006) Role of ERK in cocaine addiction. Trends Neurosci. 29, 695-703
4. Miller, G. W., Gainetdinov, R. R., Levey, A. I., and Caron, M. G. (1999) Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20, 424-429
5. Bannon, M. J., Sacchetti, P., and Granneman, J. G. (1995) in Psychopharmacology: the fourth generation of progress (Borroni, E., and Kupfer, D. J., eds) pp. 179-188, Raven Press Ltd., New York
6. Guptaroy, B., Zhang, M., Bowton, E., Binda, F., Shi, L., Weinstein, H., Galli, A., Javitch, J. A., Neubig, R. R., and Gnegy, M. (2009) A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward facing conformation. Mol. Pharmacol. 75, 514-524
7. Schmitt, K. C., and Reith, M. E. (2010) Regulation of the dopamine transporter. Aspects relevant to psychostimulant drugs of abuse. Ann. N.Y. Acad. Sci. 1187, 316-340
8. Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., and Gether, U. (2011) SLC6 neurotransmitter transporters. Structure, function, and regulation. Pharmacol. Rev. 63, 585-640
9. Steinkellner, T., Freissmuth, M., Sitte, H. H., and Montgomery, T. (2011) The ugly side of amphetamines. Short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"), methamphetamine, and D-amphetamine. Biol. Chem. 392, 103-115
10. Sitte, H. H., and Freissmuth, M. (2010) The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters. Why amphetamines take two to tango. J. Neurochem. 112, 340-355
11. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005) Mechanisms of neurotransmitter release by amphetamines. A review. Prog. Neurobiol. 75, 406-433
12. Sonders, M. S., Zhu, S. J., Zahniser, N. R., Kavanaugh, M. P., and Amara, S. G. (1997) Multiple ionic conductances of the human dopamine transporter. The actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974
13. Sitte, H. H., Huck, S., Reither, H., Boehm, S., Singer, E. A., and Pifl, C. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71, 1289-1297
14. Robertson, S. D., Matthies, H. J., and Galli, A. (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol. Neurobiol. 39, 73-80
15. --dependent neurotransmitter transporters. Drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21-55
16. Ramamoorthy, S., Shippenberg, T. S., and Jayanthi, L. D. (2011) Regulation of monoamine transporters. Role of transporter phosphorylation. Pharmacol. Ther. 129, 220-238
17. Vaughan, R. A., Huff, R. A., Uhl, G. R., and Kuhar, M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541-15546
18. Garcia, B. G., Wei, Y., Moron, J. A., Lin, R. Z., Javitch, J. A., and Galli, A. (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell surface redistribution. Mol. Pharmacol. 68, 102-109
19. Fog, J. U., Khoshbouei, H., Holy, M., Owens, W. A., Vaegter, C. B., Sen, N., Nikandrova, Y., Bowton, E., McMahon, D. G., Colbran, R. J., Daws, L. C., Sitte, H. H., Javitch, J. A., Galli, A., and Gether, U. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417-429
20. Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., and Shippenberg, T. S. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 8480-8488
21. Foster, J. D., Pananusorn, B., and Vaughan, R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 25178-25186
22. Cervinski, M. A., Foster, J. D., and Vaughan, R. A. (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and downregulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J. Biol. Chem. 280, 40442-40449
23. Granas, C., Ferrer, J., Loland, C. J., Javitch, J. A., and Gether, U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 4990-5000
24. Lu, K. P., Liou, Y. C., and Zhou, X. Z. (2002) Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12, 164-172
25. Lu, K. P., and Zhou, X. Z. (2007) The prolyl isomerase PIN1. A pivotal new twist in phosphorylation signaling and disease. Nat. Rev. Mol. Cell Biol. 8, 904-916
26. Ando, S., Ikuhara, T., Kamata, T., Sasaki, Y., Hisanaga, S., Kishimoto, T., Ito, H., and Inagaki, M. (1997) Role of the pyrrolidine ring of proline in determining the substrate specificity of cdc2 kinase or cdk5. J. Biochem. 122, 409-414
27. Gray, C. H., and Barford, D. (2003) Getting in the ring. Proline-directed substrate specificity in the cell cycle proteins Cdc14 and CDK2-cyclinA3. Cell Cycle 2, 500-502
28. Brown, N. R., Noble, M. E., Endicott, J. A., and Johnson, L. N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1, 438-443
29. Gorentla, B. K., Moritz, A. E., Foster, J. D., and Vaughan, R. A. (2009) Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48, 1067-1076
30. 125I]RTI-82). J. Labelled Compd. Radiopharm. 33, 1131-1137
31. Gu, H., Wall, S. C., and Rudnick, G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124-7130
32. Yang, J. W., Vacher, H., Park, K. S., Clark, E., and Trimmer, J. S. (2007) Trafficking-dependent phosphorylation of Kv1.2 regulates voltage-gated potassium channel cell surface expression. Proc. Natl. Acad. Sci. U.S.A. 104, 20055-20060
33. Zheng, J. F., Patil, S. S., Chen, W. Q., An, W., He, J. Q., Höger, H., and Lubec, G. (2009) Hippocampal protein levels related to spatial memory are different in the Barnes maze and in the multiple T-maze. J. Proteome Res. 8, 4479-4486
34. Gaffaney, J. D., and Vaughan, R. A. (2004) Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter. Mol. Pharmacol. 65, 692-701
35. Foster, J. D., and Vaughan, R. A. (2011) Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation. J. Biol. Chem. 286, 5175-5186
36. 125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter. J. Biol. Chem. 282, 8915-8925
37. Vaughan, R. A., and Kuhar, M. J. (1996) Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis. J. Biol. Chem. 271, 21672-21680
38. Foster, J. D., Adkins, S. D., Lever, J. R., and Vaughan, R. A. (2008) Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J. Neurochem. 105, 1683-1699
39. Lin, Z., Itokawa, M., and Uhl, G. R. (2000) Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. FASEB J. 14, 715-728
40. Henry, L. K., Iwamoto, H., Field, J. R., Kaufmann, K., Dawson, E. S., Jacobs, M. T., Adams, C., Felts, B., Zdravkovic, I., Armstrong, V., Combs, S., Solis, E., Rudnick, G., Noskov, S. Y., DeFelice, L. J., Meiler, J., and Blakely, R. D. (2011) A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. J. Biol. Chem. 286, 30823-30836
41. Scholze, P., Nørregaard, L., Singer, E. A., Freissmuth, M., Gether, U., and Sitte, H. H. (2002) The role of zinc ions in reverse transport mediated by monoamine transporters. J. Biol. Chem. 277, 21505-21513
42. Scholze, P., Sitte, H. H., and Singer, E. A. (2001) Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters. Neurosci. Lett. 309, 173-176
43. Wu, X., and Gu, H. H. (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233, 163-170
44. Giros, B., el Mestikawy, S., Bertrand, L., and Caron, M. G. (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154
45. Vaughan, R. A. (2004) Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. J. Pharmacol. Exp. Ther. 310, 1-7
46. Foster, J. D., Pananusorn, B., Cervinski, M. A., Holden, H. E., and Vaughan, R. A. (2003) Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain Res. Mol. Brain Res. 110, 100-108
47. Foster, J. D., Cervinski, M. A., Gorentla, B. K., and Vaughan, R. A. (2006) Regulation of the dopamine transporter by phosphorylation. Handb. Exp. Pharmacol., 197-214
48. Li, L. B., Chen, N., Ramamoorthy, S., Chi, L., Cui, X. N., Wang, L. C., and Reith, M. E. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012-21020
49. Carvelli, L., Morón, J. A., Kahlig, K. M., Ferrer, J. V., Sen, N., Lechleiter, J. D., Leeb-Lundberg, L. M., Merrill, G., Lafer, E. M., Ballou, L. M., Shippenberg, T. S., Javitch, J. A., Lin, R. Z., and Galli, A. (2002) PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859-869
50. Zapata, A., Kivell, B., Han, Y., Javitch, J. A., Bolan, E. A., Kuraguntla, D., Jaligam, V., Oz, M., Jayanthi, L. D., Samuvel, D. J., Ramamoorthy, S., and Shippenberg, T. S. (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J. Biol. Chem. 282, 35842-35854
51. Lee, F. J., Pei, L., Moszczynska, A., Vukusic, B., Fletcher, P. J., and Liu, F. (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26, 2127-2136
52. Hoover, B. R., Everett, C. V., Sorkin, A., and Zahniser, N. R. (2007) Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J. Neurochem. 101, 1258-1271
53. Shi, X., and McGinty, J. F. (2006) Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 138, 1289-1298
54. Sulzer, D. (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649
55. Khoshbouei, H., Sen, N., Guptaroy, B., Johnson, L., Lund, D., Gnegy, M. E., Galli, A., and Javitch, J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78
56. Sucic, S., Dallinger, S., Zdrazil, B., Weissensteiner, R., Jørgensen, T. N., Holy, M., Kudlacek, O., Seidel, S., Cha, J. H., Gether, U., Newman, A. H., Ecker, G. F., Freissmuth, M., and Sitte, H. H. (2010) The N terminus of monoamine transporters is a lever required for the action of amphetamines. J. Biol. Chem. 285, 10924-10938
57. Guptaroy, B., Fraser, R., Desai, A., Zhang, M., and Gnegy, M. E. (2011) Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters. Mol. Pharmacol. 79, 520-532
58. max. J. Neurochem. 68, 225-232
59. Kniazeff, J., Shi, L., Loland, C. J., Javitch, J. A., Weinstein, H., and Gether, U. (2008) An intracellular interaction network regulates conformational transitions in the dopamine transporter. J. Biol. Chem. 283, 17691-17701
60. Mayer, B. J. (2001) SH3 domains. Complexity in moderation. J. Cell Sci. 114, 1253-1263
61. Egaña, L. A., Cuevas, R. A., Baust, T. B., Parra, L. A., Leak, R. K., Hochendoner, S., Peña, K., Quiroz, M., Hong, W. C., Dorostkar, M. M., Janz, R., Sitte, H. H., and Torres, G. E. (2009) Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J. Neurosci. 29, 4592-4604
62. Sitte, H. H., Farhan, H., and Javitch, J. A. (2004) Sodium-dependent neurotransmitter transporters. Oligomerization as a determinant of transporter function and trafficking. Mol. Interv. 4, 38-47
63. Seidel, S., Singer, E. A., Just, H., Farhan, H., Scholze, P., Kudlacek, O., Holy, M., Koppatz, K., Krivanek, P., Freissmuth, M., and Sitte, H. H. (2005) Amphetamines take two to tango. An oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol. 67, 140-151
64. Chen, N., and Reith, M. E. (2008) Substrates dissociate dopamine transporter oligomers. J. Neurochem. 105, 910-920
65. Giambalvo, C. T. (2003) Differential effects of amphetamine transport versus dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49, 125-133
66. Lee, K. H., Kim, M. Y., Kim, D. H., and Lee, Y. S. (2004) Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem. Res. 29, 1405-1409
67. Carvelli, L., Blakely, R. D., and DeFelice, L. J. (2008) Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl. Acad. Sci. U.S.A. 105, 14192-14197
68. Binda, F., Dipace, C., Bowton, E., Robertson, S. D., Lute, B. J., Fog, J. U., Zhang, M., Sen, N., Colbran, R. J., Gnegy, M. E., Gether, U., Javitch, J. A., Erreger, K., and Galli, A. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 1101-1108
69. Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan, R. A., and Blakely, R. D. (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20, 7571-7578
70. Sossin, W. S. (2007) Isoform specificity of protein kinase Cs in synaptic plasticity. Learn Mem. 14, 236-246
71. Brändlin, I., Hübner, S., Eiseler, T., Martinez-Moya, M., Horschinek, A., Hausser, A., Link, G., Rupp, S., Storz, P., Pfizenmaier, K., and Johannes, F. J. (2002) Protein kinase C (PKC)η-mediated PKC μ activation modulates ERK and JNK signal pathways. J. Biol. Chem. 277, 6490-6496
72. Mauro, A., Ciccarelli, C., De Cesaris, P., Scoglio, A., Bouché, M., Molinaro, M., Aquino, A., and Zani, B. M. (2002) PKCα-mediated ERK, JNK, and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 115, 3587-3599
73. Clark, J. A., Black, A. R., Leontieva, O. V., Frey, M. R., Pysz, M. A., Kunneva, L., Woloszynska-Read, A., Roy, D., and Black, J. D. (2004) Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. J. Biol. Chem. 279, 9233-9247
74. Wen-Sheng, W. (2006) Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Cancer Lett. 239, 27-35
75. Guerrero, C., Lecuona, E., Pesce, L., Ridge, K. M., and Sznajder, J. I. (2001) Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L79-L85
76. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. (2001) Mitogen-activated protein (MAP) kinase pathways. Regulation and physiological functions. Endocr. Rev. 22, 153-183
77. Gold, M. G., Barford, D., and Komander, D. (2006) Lining the pockets of kinases and phosphatases. Curr. Opin. Struct. Biol. 16, 693-701